U.s. Neurosurgical, Inc. (USNU) Cash Flow Statement

Net income (loss)	495K
Depreciation and amortization	723K
Loss on impairment of Gamma Knife equipment at Kansas City center
Accounts receivable	377K
Due from related parties	8K
Other current assets	-39K
Accounts payable and accrued expenses	-19K
Net cash provided by operating activities
Investment in unconsolidated entities
Cash from settlement of Gamma Knife equipment at Kansas City center
Net cash used in investing activities
Repayment of capital lease obligations and loans payable	-672K
Decrease of cash held in escrow
Net cash used in financing activities
Net change in cash and cash equivalents	1.25M
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	1.07M
CASH AND CASH EQUIVALENTS - END OF PERIOD	2.32M
Cash paid for Interest	118K
Supplemental disclosure of noncash investing and financing activities Equipment acquired through a capital lease

Entities mentioned with USNU

View All Entities